The Trump administration on Monday announced new Medicaid drug pricing agreements with nine midsize biotechnology and pharmaceutical companies. Every drug “will be at the lowest prices available anywhere in the world,” President Trump said in the Oval Office, surrounded by company executives. Under the agreements, the companies will charge state Medicaid programs the same…
